CBCC Global Research, we are accelerating medical therapy development by providing high quality, affordable and innovative solutions.  We provide strategic solutions for all phases of clinical trials through efficient delivery of services for the flawless execution of projects, on time – every time.  We are committed to achieving excellence in all research projects by ensuring scientific validity, data integrity and compliance with the latest regulatory guidelines, thus striving to be a leading global clinical research organization (CRO).

Translational Health Science and Technology Institute (THSTI) is an autonomous Institute of the Department of Biotechnology, Ministry of Science and Technology, Govt. of India. The institute is an integral part of the interdisciplinary NCR Biotech Science Cluster located at Faridabad, and is designed as a dynamic, interactive organization with the mission to conduct innovative translational research and to develop research collaborations across disciplines and professions to translate concepts into products to improve human health.

The JAMP group is a proud Canadian owned company with its international headquarters located in Boucherville, 20 minutes from downtown Montreal, Quebec, Canada. The JAMP Pharma Group is active in all sectors of the pharmaceutical industry with our JAMP Pharma Generics, Orimed branded products, our Wampole and Laboratoire Suisse natural health supplements and our Cosmetic Import beauty and personal care products. The JAMP Pharma Group has also made a major investment in biosimilars which is one of the fastest growing markets in the pharmaceutical industry.

NIRAMAI is a health technology startup founded in July 2016. Their key offering is a Novel Cancer Detection Solution for Hospitals, Diagnostic centers, mass screening camps and home screening too. NIRAMAI is Series A funded by reputed Indian investors such as Pi Ventures, Axilor, Ankur Capital, Binny Bansal and international investors such as Dream Incubator (Japan), BeeNext (Singapore) and 500 Startups(US). NIRAMAI has won many national and international awards and recognitions.

Teva is a global pharmaceutical leader and the worlds largest generic medicines producer, committed to improving health and increasing access to quality health solutions worldwide. Our employees are at the core of our success, with colleagues in over 80 countries delivering the world's largest medicine cabinet to 200 million people every day.

Post : Regulatory Affairs Associate III - 1436

Zydus Life sciences Limited for the first time in India came up with an all women division named EQUALSTWO. Enriched with 100% natural ingredients. EOUALSTWO offers quality skincare products made from the best of nature and science. Built on the foundation of balance the division aims to win the trust of mothers with a 100% natural and safe product range which is at par with international standards of skin care.

Genpact Limited, a global leader in business process and technology management services, leverages the power of smarter processes, smarter analytics and smarter technology to help its clients drive intelligence across the enterprise. Genpacts Smart Enterprise Processes (SEP) framework, its unique science of process combined with deep domain expertise in multiple industry verticals, leads to superior business outcomes.

Post : Lead Associate - Regulatory Affairs-LIF007376

Rusan Pharma Ltd. is a fully integrated global pharmaceutical company specializing in the treatment of Addiction and Pain Management.  We offer a complete range of products for de-addiction and pain management in countries across the globe including Europe, UK, Russia, CIS, South Africa, Mauritius, Nepal and Myanmar. We are one of the largest suppliers of life saving drugs to various organizations such as NACO, UNODC, UNOPS, Global Fund and Ministries of health in various emerging markets.

SMS Pharmaceuticals Ltd. is a global player in API manufacturing having a strong research and manufacturing team supported by state of the art facilities. What started off as a single facility single product manufacturing company in 1990 grew to be a multi-location group having product list spreading across an array of therapeutic segments. SMS was given the export house status in the year 1997-98. SMS is currently a listed company having ever appreciating international and domestic customer base.